CIK 0001759138 · Non-accelerated filer<br>Smaller reporting company
Cabaletta Bio, Inc.
Sign in to watch- Ticker
- CABA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (267) 759-3100
- Business address
- 2929 ARCH STREET, SUITE 600, PHILADELPHIA, PA, 19104
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-10-29 | 5AM Ventures V, L.P. 10% owner | Conversion · Series B Preferred Stock | −1,675,532 | 0 | ||
| 2019-10-29 | Flynn James E 10% owner | Conversion | +464,253 | 464,253 | ||
| 2019-10-29 | Flynn James E 10% owner | Conversion | +464,253 | 464,253 | ||
| 2019-10-29 | Flynn James E 10% owner | Purchase | +700,000 | $11.00 | $7.7M | 700,000 |
| 2019-10-29 | Flynn James E 10% owner | Conversion · Series B Preferred Stock | −696,379 | 0 | ||
| 2019-10-29 | Flynn James E 10% owner | Conversion · Series B Preferred Stock | −696,379 | 0 | ||
| 2019-10-29 | Simon Mark Director | Conversion | +18,144 | 18,144 | ||
| 2019-10-29 | Simon Mark Director | Conversion · Series A-1 Preferred Stock | −27,217 | 0 | ||
| 2019-10-29 | Nichtberger Steven President & CEO | Conversion | +60,483 | 786,483 | ||
| 2019-10-29 | Nichtberger Steven President & CEO | Conversion · Series A-1 Preferred Stock | −90,725 | 0 | ||
| 2019-10-29 | Redmile Group, LLC 10% owner | Conversion | +696,378 | 696,378 | ||
| 2019-10-29 | Redmile Group, LLC 10% owner | Conversion · Series B Convertible Preferred Stock | −1,044,568 | 0 | ||
| 2019-10-24 | Binder Gwendolyn EVP, Science & Technology | Grant or award · Stock Option (Right to Buy) | +29,908 | 29,908 | ||
| 2019-10-24 | Marda Anup Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +66,463 | 66,463 | ||
| 2019-10-24 | Nichtberger Steven President & CEO | Grant or award · Stock Option (Right to Buy) | +99,714 | 99,714 | ||
| 2019-10-24 | Chang David J. Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +48,836 | 48,836 |
Page 13 of 13 · 256 trades